ENTA - Enanta Pharma GAAP EPS of -$1.79 beats by $0.13 revenue of $17.8M misses by $1.26M May, 08 2023 04:07 PM Enanta Pharmaceuticals Inc. 2023-05-08 16:07:41 ET Enanta Pharma press release ( NASDAQ: ENTA ): FQ2 GAAP EPS of -$1.79 beats by $0.13 . Revenue of $17.8M (-4.8% Y/Y) misses by $1.26M . For further details see: Enanta Pharma GAAP EPS of -$1.79 beats by $0.13, revenue of $17.8M misses by $1.26M